Clinic’s psychedelic drugs and music therapy is not so far out
The centre, run by the pharmaceutical start-up Clerkenwell Health, will provide Europe’s first commercial setting for clinical trials of psychedelic drugs when it opens this summer.
It is a response to a body of evidence that psychedelics — long overlooked by the medical profession — have enormous potential to treat mental illness.
For Sponsors & CROs
Partner with our clinical trial network for CNS research.
Sign up to hear about new studies as they open.